Stock Performance - As of February 11, 2026, the stock price of Feiwo Tai closed at 20.88 CNY per share, with a market capitalization of approximately 7.035 billion CNY [2] - The stock has seen a cumulative decline of 6.51% over the last five trading days, but has increased by 2.69% over the past 20 days [2] - On the same day, there was a net inflow of 176,000 CNY in main funds, marking the second consecutive day of net inflow [2] Business Development - Feiwo Tai's nano-film products have entered the supply chains of AI glasses and smartwatches, becoming suppliers for major companies like Huawei, Xiaomi, and Apple [3] - The company's nano-protection technology is applied in medical devices such as endoscopes and ultrasonic knives, having passed ISO13485 quality management certification [3] - The company is actively cooperating with other clients for sample verification, with future demand expected to rise alongside growth in the medical device market [3] - Feiwo Tai has expanded its international presence with subsidiaries in Hong Kong, the USA, and Vietnam, and is continuing to explore markets in India, Malaysia, and Pakistan [3] Financial Performance - For the first three quarters of 2025, Feiwo Tai reported a revenue of 367 million CNY, representing a year-on-year growth of 6.00% [4] - The net profit attributable to shareholders was 28.9777 million CNY, reflecting a year-on-year increase of 6.45% [4] - The basic earnings per share stood at 0.09 CNY, with the number of shareholders decreasing by 8.60%, indicating an increase in share concentration [4] Future Outlook - The annual report for 2025 is expected to be released in the first half of 2026, and investors should monitor the performance realization [5] - Future business catalysts include verification results from medical device clients, progress on new orders, and policies in the electronic chemicals industry, such as semiconductor localization [5]